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INTRODUCTION 22
Neurofibromatosis type 1 (NF1) is a genetic disorder affecting 1 in ~3,500 individuals. Caused 23 by mutations in the NF1 gene, this disorder is characterized by benign tumors of the nervous 24 system called neurofibromas, as well as an increased susceptibility to a range of complications 25
including various cancers and neurocognitive deficits (e.g., attention-deficit/hyperactivity 26 disorder, autism spectrum disorder, visuospatial memory impairments) (Diggs-Andrews and 27
Gutmann, 2013; Hyman et al., 2005) . The NF1 tumor suppressor gene encodes a large protein 28 called neurofibromin, which contains a central GAP-related domain (GRD) that enhances the 29 GTPase activity of the small guanine nucleotide binding protein Ras, thereby down-regulating its 30 biological activity (Cichowski and Jacks, 2001; Ratner and Miller, 2015) . Ras, in turn, signals 31 through multiple effectors, including mTOR, ERK, and, potentially cAMP/PKA indirectly (Gehart 32 et al., 2010) . Due to the numerous cellular functions of Ras, as well as potential interactions of 33 neurofibromin with other signaling molecules (Ho et Emerging evidence suggests that NF1 regulates cellular and organismal metabolism. NF1 has 40 been associated with short stature, as well as reduced body mass index in males (Koga et al., 41 2016; Souza et al., 2016) , although the mechanisms underlying these manifestations are 42 unknown. Alterations in certain metabolites have been reported in NF1 patients, though these 43 are sex-specific (Koga et al., 2016) . The incidence of diabetes mellitus, deaths from diabetes 44 mellitus, and fasting blood glucose levels are lower in individuals with NF1 than in healthy 45 controls (Martins et al., 2016) . Of potential importance for NF1-associated tumorigenesis, loss 46 4 of NF1 increases glycolysis and decreases respiration via Ras/ERK signaling in mitochondria 47 (Masgras et al., 2017) . Finally, increased resting energy expenditure has been reported in 48 females with NF1 (Souza et al., 2019) . Therefore, NF1 has the potential to regulate cellular and 49 organismal metabolism, and alterations in metabolism may contribute to its pathophysiology. 50
However, clinical studies have produced sometimes contradictory results across cohorts/sexes, 51 often include low sample sizes, and the multisystemic nature of the disorder precludes 52 
Loss of dNf1 increases metabolic rate via neuronal mechanisms 68
To test whether dNf1 affects metabolic rate, we examined CO2 production via respirometry ( Fig.  69 1A) (Yatsenko et al., 2014) . In insects, whole body CO2 production provides a readout of 70 metabolic rate and can be readily measured in freely moving animals (Lighton, 2008) . We first 71 compared Nf1 P1 mutants, which harbor a large deletion in the dNf1 locus, including the central 72 catalytic GRD (The et al., 1997) , with w CS10 controls. Nf1 P1 mutant adult flies exhibited 73 significantly elevated CO2 output compared to controls ( Fig. 1B and S1A ), suggesting that dNf1 74 plays a role in metabolic regulation. For additional confirmation, we tested a heteroallelic 75 combination of the Nf1 P1 deletion with a nonsense mutation, Nf1 E1 (Walker et al., 2006) . Nf1 P1/E1 76 mutants also exhibited significantly elevated CO2 output relative to w CS10 control flies ( Fig. 1C  77 and S1B). To test whether the effect observed in dNf1 mutants is localized to neurons, we 78 knocked down dNf1 with RNAi using the Gal4/UAS system. In independent experiments, two 79 different pan-neuronal Gal4 drivers were used to drive the RNAi: nSyb-Gal4 and R57C10-Gal4. 80
In each case, a significant elevation in CO2 production was observed in the experimental group 81 relative to flies harboring either the heterozygous driver (Gal4/+) or effector (UAS/+) transgenes 82 alone ( Fig. 1D and S1C ). This suggests that the loss of dNf1 function elevates metabolic rate 83 via neuronal mechanisms. 84
85
To identify the neurons responsible for the increase in CO2 production, we knocked down dNf1 86 using neuronal subset-selective Gal4 drivers. Drivers were selected that express in neurons 87 production in Nf1 P1 mutants and w CS10 controls, with mutants normalized to controls. **p < 0.01 (Mann-Whitney, n = 9). (C) Normalized CO 2 production in heteroallelic Nf1 P1/E1 mutants and matched genetic background controls. ***p < 0.001 (Mann-Whitney, n = 11-12). (D) CO 2 production when dNf1 was knocked down with RNAi driven by pan-neuronal Gal4 lines: nSyb-and R57C10-Gal4. Gal4/+ and UAS/+ are heterozygous controls. For each driver, data are normalized to the mean of both controls. ***p < 0.001 (Dunn's test, n = 8-12). (E) Screen for neuronal subsets in which knocking down dNf1 elevates CO 2 production. Normalized CO 2 production from each Gal4 line is shown. (F) Significant lines from panel E, showing both RNAi and heterozygous control groups. *p < 0.05, **p < 0.01, ***p < 0.001 (Dunn's test, n = 7-14). (G) Normalized CO 2 production when knocking down dNf1 pan-neuronally with R57C10-Gal4, with and without the addition of the tsh-Gal80 repressor. ***p < 0.001 (Sidak, n = 6).
6 previously characterized dNf1 effects on growth in larvae (e.g., Ras2) (Walker et al., 2006) . For 90 each line, the experimental group was compared to the two heterozygous genetic controls 91 (Gal4/+ and UAS/+) within experiments. Among the 45 lines tested, 5 lines exhibited significant 92 elevation of metabolic rate relative to both controls ( Fig. 1 E,F and S1E). The positive lines 93 were, in descending order of effect size, PCB, 69B, Ras2(41), Ras2(12), and tsh ( Fig. 1F and 94 S1E). The PCB-Gal4, described in more detail below, expresses in a sparse subset of neurons 95 in the nervous system. The 69B and Ras2 drivers express broadly across the nervous system. 96
Within neurons, the tsh-Gal4 line expresses preferentially in the ventral nervous system (VNS), 97
suggesting that neurons in the VNS may be a major contributor to the metabolic phenotype. To 98 further localize the effect, we parsed the brain and VNS with an intersectional approach. We 99 drove the dNf1 RNAi pan-neuronally with R57C10 in one set of flies and suppressed VNS 100 expression with the tsh-Gal80 repressor in another group ( Fig. 1G and S1D). The tsh-Gal80 101 repressor differentially removes expression from neurons in the VNS (Clyne and Miesenbock, 102 2008). Limiting expression with tsh-Gal80 eliminated the metabolic phenotype, suggesting that 103 dNf1-sensitive neurons are tsh-positive, and may reside in the VNS. 104
105
The mapping experiments revealed several major aspects of the dNf1-mediated neuronal 106 control of metabolism. First, the dNf1 effect on metabolic rate was not due to the effects on a 107 selective neurotransmitter system or neuronal subset (notably GABAergic and cholinergic 108 neurons and neurons that release insulin-like peptides). Instead, knocking down dNf1 in 109 relatively broader sets of neurons in the brain and/or VNS was required to drive an increase in 110 metabolic rate. The driver with the most restricted expression pattern that produced a large 111 effect was the PCB-Gal4 driver ( Fig. 2A) . This driver has a Gal4 enhancer trap in the pyruvate 112 carboxylase (PCB) locus, and it has been previously termed "fatbody-Gal4" due to positive 113 expression in the fat body (Gronke et al., 2003) . However, our experiments suggest that the Expression of GFP (green) in neurons labeled by the PCB-Gal4 driver. Bruchpilot (brp) was used to counterstain neuropil (magenta). (B) CO 2 production assayed by respirometry. dNf1 was knocked down in neurons with the PCB-Gal4 driver, with or without the elav-Gal80 repressor. The PCB-Gal4 without Gal80 data set is the same as in Figure 1 , shown here for comparison. ns: not significant. **p < 0.01 ***p < 0.001 (Dunn's test, n = 5-7). 7 metabolic phenotype is neuronal in origin. Therefore, we tested whether this driver also exhibits 115 neuronal expression. Using the PCB-Gal4 to drive green fluorescent protein (mCD8::GFP, we 116 fixed and immunostained adult brains and VNS, and found sparse but robust GFP expression in 117 neurons in both regions ( Fig. 2A) . Given that the driver is not fat body-specific, we propose that 118 it be referred to by its genomic locus (PCB-Gal4) and do so here. consumption and CO2 production across the 24-hr photoperiod relative to controls ( Fig. 3 B,D) . 137
These differences were significant when the data were binned into both day and night periods 138 Fig. 3 C,E) . Similarly, when dNf1 was knocked down pan-neuronally using nSyb-Gal4, we 139 observed increased O2 consumption and CO2 production across the circadian photoperiod 140 relative to controls (Fig. 3 G-J) . In both cases, the respiratory quotient (RQ), the ratio of CO2 141 eliminated to O2 consumed, was significantly reduced in dNf1 loss of function ( Fig. 3 F,K) . 142
Decreased RQ is consistent with increased utilization of endogenous fat stores (Stahl et al., 143 2017 ), suggesting that loss of dNf1 may increase fat utilization, a possibility we consider further 144 below. Overall, these data provide independent support for the role of dNf1 in metabolic 145 regulation, demonstrate that it is consistent across the 24-hr photoperiod, and suggest that it 146 may result from altered fat homeostasis. 147 148
Metabolic regulation is independent of grooming 149
Loss of dNf1 increases spontaneous grooming (King et al., 2016) , which could drive an increase 150 in energy expenditure. To test whether this accounts for the increase in metabolic rate 151 observed here, we knocked down dNf1 and quantified grooming in an open field arena ( Fig.  152 4A). Pan-neuronal knockdown of dNf1 elevated spontaneous grooming (Fig. 4B ), as previously 153
reported (King et al., 2016) . In addition, we tested the more restricted PCB-Gal4 driver. While 154 knocking down dNf1 with this driver produced one of the largest increases in metabolic rate 155 ( Fig. 1 E,F) , it did not significantly elevate spontaneous grooming (Fig. 4C) . Therefore, dNf1 156 functions in independent populations of neurons to regulate metabolic rate and grooming. 157
Further, these findings reveal that the elevated metabolic rate observed in dNf1 mutant flies is 158 not due to changes in grooming. Alterations in metabolic rate could be expected to affect lipid storage, and the decreased 163 respirometry quotient suggests that lipid stores may be reduced. To directly test this, we first 164 quantified triglyceride content using coupled colorimetry ( Fig. 5A) (Tennessen et al., 2014) . 165
Triglyceride stores were significantly reduced in dNf1 mutants compared to controls (Fig. 5A) . 166
Changes in either lipogenesis or lipolysis can decrease triglyceride levels (Fig. 5B ). To 167 determine which of these processed is dysregulated, we examined lipid turnover in a pulse-168 chase experiment (Fig. 5C ). Flies were fed radiolabeled 14 C sucrose for 24 hr. Incorporation of 169 14 C sucrose into fatty acids in the flies was measured with scintillation at 0 hr or 48 hr after 170 returning flies to normal, unlabeled food. Initial incorporation of 14 C did not differ between 171 controls and Nf1 P1 mutants, suggesting that the synthesis of fatty acids (i.e., lipogenesis rate) 172 was unchanged ( Fig. 5D ). However, after 48 hr, Nf1 P1 flies retained significantly less 14 C than 173 controls, suggesting that the mutants exhibited increased rates of lipolysis. The effect was 174 significant regardless of whether incorporation was normalized to body weight or the number of 175 flies (data not shown). Together, these findings suggest that lipid levels are reduced in dNf1 176 mutant flies due to increased lipolysis. 177
178
Triglycerides provide a major source of nutrients in flies that is critical for survival in nutrient-179 poor conditions. To determine whether the reduced triglyceride levels and increased metabolic 180 rate impact survival in the absence of food, we measured the starvation resistance of Nf1 P1 181 mutants and controls flies. dNf1 mutants were significantly more susceptible to starvation, 182 succumbing in less than half the time of control flies when housed on a nutrient-free agar media 183 ( Fig. 5E ). This suggests that loss of dNf1 increases starvation susceptibility, potentially due to 184 the altered lipid homeostasis, which leaves the flies with lower reserves to draw on during (D) Quantification of lipid turnover via 14 C sucrose radiolabeling. Radioactivity was measured as counts per minute (CPM) and normalized to fly weight (mg). ns: not significant, ***p < 0.001 (Sidak; n = 6). (E) Lifespan under starvation, comparing Nf1 P1 mutants (n = 78) and w CS10 controls (n = 80). *** p < 0.0001 (X 2 (1) = 154.0, Mantel-Cox test).
Loss of dNf1 increases feeding in adult flies 188
Feeding and energy stores are homeostatically regulated, and animals often compensate for 189 depleted energy stores by increasing food intake. Since loss of dNf1 increased metabolic rate, 190 decreased lipid stores, and increased lipid turnover via increased lipolysis, energy intake could 191 be increased as a homeostatic compensatory mechanism. To test this, we examined feeding 192 using a capillary feeding assay (Murphy et al., 2017) (Fig. 6A ). Food intake was significantly 193 increased in Nf1 P1 adult flies relative to controls (Fig. 6B ). Knocking down dNf1 pan-neuronally 194 also increased feeding relative to controls (Fig. 6C) , confirming the effect and suggesting that it 195 was due to the loss of dNf1 specifically in neurons. We next tested the neuronal circuit 196 requirements for dNf1 in the context of feeding. A selection of Gal4 drivers that labeled different 197 neurochemical subsets, and/or produced metabolic alterations, were used to drive dNf1 RNAi 198 ( Fig. 6D ). Among these lines, significant elevations in feeding were observed when dNf1 was 199 knocked down pan-neuronally (nSyb), selectively in the VNS (tsh), and in subsets of neurons 200 labeled by the 69B and PCB-Gal4 drivers. No effect was observed when dNf1 was knocked 201 down in GABAergic neurons (GAD) or insulin-like peptides (ILP2, ILP3, ILP5, ILP 6, ILP7) ( Fig.  202   6D) . Thus, knocking down dNf1 in the same circuits that elevated metabolic rate ( Fig. 1 E,F ) 203 also drove an increase in feeding. While it is possible that dNf1 independently regulates both 204 phenotypes via actions in the same circuit(s), we surmise that the increase in feeding is likely a 205 homeostatic response to the increase in metabolic rate and decrease in fat stores caused by 206 loss of dNf1. (Cichowski and Jacks, 2001; Ratner and Miller, 2015) . To determine the critical cellular 212 signaling pathway(s) mediating dNf1 effects on metabolic rate, we first tested the role of the 213 GRD. We utilized the UAS/Gal4 system to express dNf1 in flies with the heteroallelic Nf1 P1/E1 214 mutant combination. Pan-neuronal rescue of full-length, wild-type dNf1 restored metabolic rate 215 to control levels ( Fig. 7 A,B) . In contrast, pan-neuronal expression of full-length dNf1 carrying a 216 missense mutation in the "arginine finger" of the GRD, R1320P, did not rescue the metabolic 217 effect ( Fig. 7 A,B) . This mutation corresponds to the patient-derived R1276P mutation in NF1 218
shown to reduce Ras GAP activity >1000 fold (Klose et al., 1998; Walker et al., 2006) . These 219 data suggest that expression of wild-type dNf1 in neurons restores normal metabolic rate and 220 that RasGAP activity is necessary for dNf1 metabolic effects. of neurons to modulate metabolic rate. These neurons were not ones commonly implicated in 236 metabolism, feeding, or organismal growth, as knocking down dNf1 in insulin-producing cells, 237 peptidergic neurons, ring gland cells, monoaminergic neurons, etc., produced no effect. It was 238 particularly surprising that loss of dNf1 function in the insulin-producing cells yielded no 239 significant changes in metabolism or feeding, as the insulin-like peptides released by these 240 neurons are functional homologs of insulin and insulin-like growth factors. Furthermore, 241 alterations to such cells affect starvation response and lipid stores (Baker and Thummel, 2007) . 242
243
A sparse set of neurons in the nervous system, labeled most discretely by the PCB-Gal4 driver, 244 was responsible for the dNf1 effect on metabolism. Due to additional fat body expression with 245 this driver, we verified that the metabolic phenotype was due to loss of neuronal dNf1, using 246 additional Gal4 lines that express in the adult and larval fat body. The fat body serves an 247 important homeostatic function by storing lipids, similarly to white adipose tissue in mammals, 248
and plays a role in the regulation of peripheral tissues under both fed and starved conditions 249 (Baker and Thummel, 2007) . Therefore, the lack of metabolic effects with multiple fat body 250 specific drivers was notable. The effects of dNf1 on metabolic rate could theoretically be due to 251 altered energy expenditure within neurons themselves or central control of metabolism. Our 252 experiments implicate the latter, as the PCB-Gal4 driver labels a sparse neuronal population 253 and drives a robust metabolic effect when used to knock down dNf1. 254 255 A previous study from our group observed increased grooming activity in dNf1 mutants and with 256 pan-neuronal RNAi. Increased locomotor activity, including activity such as grooming, might be 257 expected to drive increases in metabolism. However, the dNf1 metabolic and grooming 258 phenotypes were dissociable with the PCB-Gal4 driver, which increased metabolic rate without 259 13 increasing grooming. Thus, we surmise that the effects of dNf1 on grooming and metabolic rate 260 are caused by distinct neuronal circuits, with relatively little overlap. A thorough analysis of the 261 neuronal circuit driving both phenotypes (particularly grooming) will be necessary to understand 262 how dNf1 independently modulates these behaviors. wild-type neurofibromin restored normal metabolic rate in dNf1 mutants. However, expression 280 of a dNf1 transgene containing the catalytically dead R1320P mutation failed to rescue. This 281 mutation recapitulates the human patient-derived R1276P mutation that impacts the arginine 282 finger of the GRD, reducing RasGAP activity >1000 fold (Klose et al., 1998) . In addition to the 283 GRD, neurofibromin contains other domains with potential functional significance, such as a 284 lipid-binding pleckstrin-homology domain (Fig. 7) . Thus, this experiment demonstrated that 285 catalytic activity from the GRD itself was critical for dNf1 modulation of metabolic rate, rather Alterations in specific metabolites have been reported, though these are sex-specific (Koga et 301 al., 2016) . Diabetes mellitus -as well as deaths from noted diabetes complications -is rare in 302 patients with NF1 (Koga et al., 2016) . Loss of NF1 increases glycolysis and decreases 303 respiration via mitochondrial ERK signaling, which may play a role in tumor growth (Masgras et 304 al., 2017) . Finally, increased resting energy expenditure was recently reported in a cohort of 305 female NF1 patients as well as a decrease in respiratory quotient compared to healthy controls 306 (Souza et al., 2019) . Therefore, NF1 has the potential to regulate cellular and organismal 307 metabolism, and alterations in metabolism may contribute to the pathophysiology of NF1. Our 308 CO2 and allowed to recover for at least 24 hr before beginning the experiment. Four flies of the 355 same genotype were placed into each pipette using an aspirator and tightly sealed at the top 356 using non-hardening modeling clay. One pipette was left empty in each chamber as a 357 temperature and atmospheric control. The measuring chamber was filled with 500mL red-dye 358 solution made with water-based dye. The latch-lid chamber with flies were left to equilibrate to 359 incubator conditions (25 ºC) for 1 hr before starting the experiment. Vacuum grease was applied 360 between the latch-lid and chamber to reduce atmospheric and temperature fluctuations. Images 361 were captured every 15 minutes using a time-lapse image software (PhenoCapture) and 362 analyzed using Fiji, measuring the liquid meniscus position in each capillary. This measurement 363 was subtracted from a reference image and repeated at each time point for 3 hr. 364 365
Indirect calorimetry 366
Metabolic rate was measured using the Sleep and Activity Metabolic Monitor (SAMM) system at 367 25 ºC through indirect calorimetry using a stop-flow, push-through respirometry system (Sable 368 Systems International). Metabolic rate in group-housed adult flies was measured as previously 369 described (Stahl et al., 2018; Stahl et al., 2017) . Briefly, the experimental system assessed 370 baseline CO2 levels from an empty chamber to measure CO2 production and O2 consumption 371 from 25 male adult flies. Air was flushed from each chamber for 50 sec to provide a readout of 372 CO2 accumulation and O2 consumption over a 10-min period. A H2O and CO2 scrubber was 373 used to dehumidify and remove CO2 from air before being pumped into a mass flow control 374 valve to maintain a consistent flow rate. The air was then re-humidified by passing through a 375 reservoir containing deionized water prior to reaching the behavioral chambers. Each behavioral 376 chamber (70 mm long x 20 mm diameter glass tube) contained 25 adult male flies with a food 377 vial containing 1% agar and 5% sucrose. Flies were allowed to acclimate to system for 24 hr 378 before the start of each experiment. All experimental runs included a food-only control baseline 379
